BIO-RAD LABORATORIES, INC. Debt and Equity Securities, Unrealized Gain (Loss)
BIO-RAD LABORATORIES, INC. (BIO.B) reported Debt and Equity Securities, Unrealized Gain (Loss) of $900.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss · last filed 2026-02-13
- BIO-RAD LABORATORIES, INC. debt and equity securities, unrealized gain (loss) for the quarter ending 2021-12-31 was $10.80M.
- BIO-RAD LABORATORIES, INC. debt and equity securities, unrealized gain (loss) for fiscal 2025 was $900.40M.
- BIO-RAD LABORATORIES, INC. debt and equity securities, unrealized gain (loss) for fiscal 2024 was -$2.66B.
- BIO-RAD LABORATORIES, INC. debt and equity securities, unrealized gain (loss) for fiscal 2023 was -$1.25B.
- BIO-RAD LABORATORIES, INC. debt and equity securities, unrealized gain (loss) for fiscal 2022 was -$5.19B, a 205.43% decline from fiscal 2021.
| Period end | Debt and Equity Securities, Unrealized Gain (Loss) 3 month | Debt and Equity Securities, Unrealized Gain (Loss) 12 month | Debt and Equity Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $900.40M 10-K · filed 2026-02-13 | ||
| 2024-12-31 | -$2.66B 10-K · filed 2026-02-13 | ||
| 2023-12-31 | -$1.25B 10-K · filed 2026-02-13 | -$1.25B 10-K · filed 2024-02-16 | |
| 2022-12-31 | -$5.19B 10-K · filed 2025-02-14 | -$5.19B 10-K · filed 2023-02-17 | |
| 2021-12-31 | $10.80M 10-K · filed 2022-02-11 | $4.93B 10-K · filed 2024-02-16 | |
| 2020-12-31 | $4.50B 10-K · filed 2023-02-17 | ||
| 2019-12-31 | $2.03B 10-K · filed 2022-02-11 |